1. Home
  2. News
  3. BCAL Diagnostics Limited
  4. BCAL Takes Interest in Genetic Signatures to 18.46%
More BCAL Diagnostics Limited news
BCAL Diagnostics LimitedASX: BDX

BCAL Takes Interest in Genetic Signatures to 18.46%

Aug 25, 2026 at 7:18 PM EDT · Issued by BCAL Diagnostics Limited

Filed with ASX · Aug 25, 2026 at 7:18 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/bcal-takes-interest-in-genetic-signatures-to-18.46percent

BCAL Diagnostics Limited on 6ix

Story so far

  • BCAL to Acquire Shares in Genetic SignaturesJul 2, 2026

Earlier from BCAL Diagnostics

  • Change in Substantial Shareholder Notice for GSSAug 25
  • Notification regarding unquoted securities - BDXAug 25
  • BCAL Secures Funding for FY2027 UpdateAug 21
  • Proposed issue of securities - BDXAug 21
  • Bioshares Conference Investor PresentationAug 5

Later from BCAL Diagnostics

  • Appendix 4G and Corporate Governance StatementAug 28
  • Appendix 4E and Annual Report to shareholdersAug 28
  • Meet The CEO FY 2026 Results Webinar 3 Sept 2026 at 1PMAug 31
  • Investor Presentation September 2026Sep 2
  • BCAL Seeks Board Change at Genetic SignaturesSep 2
All BCAL Diagnostics news releases↗

Follow BCAL Diagnostics into a list and get an email when it puts out news.

Follow BCAL Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer